50+
installs · ≈59
—
0 ratings
2024-04-22
first release
2026-11-02
last update
Description
You are invited to participate in the Daiichi Sankyo - DS7300-188 study.
A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.
What's new
Bug fixes
Details
| Version | 5.5.901.1-prod |
|---|---|
| Minimum Android version | 8.0 |
| Reviews | 0 |
| Available in | American Samoa, Australia, Belgium, St. Barthélemy, Brazil, Canada, Switzerland, Germany, Spain, France, United Kingdom, French Guiana and 23 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-15 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.ds7300188"
